Home
/
RESMED INC
/
Financials
/
Quarterly
RESMED INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that RESMED INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Mar 31, 2020
$769.46M
May 1, 2020
Q2
2020
Dec 31, 2019
$736.16M
Jan 31, 2020
Q1
2020
Sep 30, 2019
$681.06M
Oct 25, 2019
Q3
2020
Mar 31, 2019
$662.23M
May 1, 2020
Q2
2020
Dec 31, 2018
$651.10M
Jan 31, 2020
Q1
2020
Sep 30, 2018
$588.28M
Oct 25, 2019
Q3
2019
Mar 31, 2018
$591.63M
May 3, 2019
Q2
2019
Dec 31, 2017
$601.27M
Feb 1, 2019
Q1
2019
Sep 30, 2017
$523.66M
Oct 26, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$1.42B
Jan 30, 2026
Q1
2026
Sep 30, 2025
$1.34B
Oct 31, 2025
Q3
2025
Mar 31, 2025
$1.29B
Apr 24, 2025
Q2
2026
Dec 31, 2024
$1.28B
Jan 30, 2026
Q1
2026
Sep 30, 2024
$1.22B
Oct 31, 2025
Q3
2025
Mar 31, 2024
$1.20B
Apr 24, 2025
Q2
2025
Dec 31, 2023
$1.16B
Jan 31, 2025
Q1
2025
Sep 30, 2023
$1.10B
Oct 25, 2024
Q3
2024
Mar 31, 2023
$1.12B
Apr 26, 2024
Q2
2024
Dec 31, 2022
$1.03B
Jan 25, 2024
Q1
2024
Sep 30, 2022
$950.29M
Oct 27, 2023
Q3
2023
Mar 31, 2022
$864.50M
Apr 28, 2023
Q2
2023
Dec 31, 2021
$894.87M
Jan 27, 2023
Q1
2023
Sep 30, 2021
$904.02M
Oct 28, 2022
Q3
2022
Mar 31, 2021
$768.77M
Apr 29, 2022
Q2
2022
Dec 31, 2020
$800.01M
Jan 28, 2022
Q1
2022
Sep 30, 2020
$751.94M
Oct 29, 2021
Q3
2021
Mar 31, 2020
$769.46M
Apr 30, 2021
Q2
2021
Dec 31, 2019
$736.16M
Jan 29, 2021
Q1
2021
Sep 30, 2019
$681.06M
Oct 30, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Mar 31, 2016
$453.88M
Apr 29, 2016
Q2
2016
Dec 31, 2015
$454.54M
Jan 28, 2016
Q1
2016
Sep 30, 2015
$411.65M
Oct 27, 2015
Q3
2016
Mar 31, 2015
$422.50M
Apr 29, 2016
Q2
2016
Dec 31, 2014
$422.95M
Jan 28, 2016
Q1
2016
Sep 30, 2014
$380.40M
Oct 27, 2015
Q3
2015
Mar 31, 2014
$397.76M
Apr 29, 2015
Q2
2015
Dec 31, 2013
$384.34M
Jan 30, 2015
Q1
2015
Sep 30, 2013
$357.66M
Oct 31, 2014
Q3
2014
Mar 31, 2013
$383.58M
May 1, 2014
Q2
2014
Dec 31, 2012
$376.54M
Jan 29, 2014
Q1
2014
Sep 30, 2012
$339.73M
Oct 30, 2013
Q3
2013
Mar 31, 2012
$349.07M
May 1, 2013
Q2
2013
Dec 31, 2011
$332.74M
Jan 31, 2013
Q1
2013
Sep 30, 2011
$314.77M
Oct 31, 2012
Q3
2012
Mar 31, 2011
$313.26M
May 1, 2012
Q2
2012
Dec 31, 2010
$305.99M
Feb 2, 2012
Q1
2012
Sep 30, 2010
$282.01M
Nov 3, 2011
Q3
2011
Mar 31, 2010
$278.66M
May 3, 2011
Q2
2011
Dec 31, 2009
$275.13M
Feb 3, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$392.59M
Jan 30, 2026
Q1
2026
Sep 30, 2025
$348.54M
Oct 31, 2025
Q2
2026
Sep 30, 2025
$348.54M
Jan 30, 2026
Q3
2025
Mar 31, 2025
$365.04M
Apr 24, 2025
Q2
2026
Dec 31, 2024
$344.62M
Jan 30, 2026
Q3
2025
Dec 31, 2024
$344.62M
Apr 24, 2025
Q1
2026
Sep 30, 2024
$311.36M
Oct 31, 2025
Q2
2026
Sep 30, 2024
$311.36M
Jan 30, 2026
Q3
2025
Sep 30, 2024
$311.36M
Apr 24, 2025
Q3
2025
Mar 31, 2024
$300.49M
Apr 24, 2025
Q2
2025
Dec 31, 2023
$208.80M
Jan 31, 2025
Q3
2025
Dec 31, 2023
$208.80M
Apr 24, 2025
Q3
2025
Sep 30, 2023
$219.42M
Apr 24, 2025
Q2
2025
Sep 30, 2023
$219.42M
Jan 31, 2025
Q1
2025
Sep 30, 2023
$219.42M
Oct 25, 2024
Q3
2024
Mar 31, 2023
$232.50M
Apr 26, 2024
Q2
2024
Dec 31, 2022
$224.91M
Jan 25, 2024
Q3
2024
Dec 31, 2022
$224.91M
Apr 26, 2024
Q1
2024
Sep 30, 2022
$210.48M
Oct 27, 2023
Q2
2024
Sep 30, 2022
$210.48M
Jan 25, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$491.66M
Jan 30, 2026
Q1
2026
Sep 30, 2025
$446.54M
Oct 31, 2025
Q3
2025
Mar 31, 2025
$426.27M
Apr 24, 2025
Q2
2026
Dec 31, 2024
$417.24M
Jan 30, 2026
Q1
2026
Sep 30, 2024
$387.31M
Oct 31, 2025
Q3
2025
Mar 31, 2024
$374.58M
Apr 24, 2025
Q2
2025
Dec 31, 2023
$275.09M
Jan 31, 2025
Q1
2025
Sep 30, 2023
$289.00M
Oct 25, 2024
Q3
2024
Mar 31, 2023
$300.67M
Apr 26, 2024
Q2
2024
Dec 31, 2022
$280.19M
Jan 25, 2024
Q1
2024
Sep 30, 2022
$275.74M
Oct 27, 2023
Q3
2023
Mar 31, 2022
$234.27M
Apr 28, 2023
Q2
2023
Dec 31, 2021
$248.71M
Jan 27, 2023
Q1
2023
Sep 30, 2021
$261.91M
Oct 28, 2022
Q3
2022
Mar 31, 2021
$223.43M
Apr 29, 2022
Q2
2022
Dec 31, 2020
$221.72M
Jan 28, 2022
Q1
2022
Sep 30, 2020
$216.90M
Oct 29, 2021
Q3
2021
Mar 31, 2020
$217.50M
Apr 30, 2021
Q2
2021
Dec 31, 2019
$197.81M
Jan 29, 2021
Q1
2021
Sep 30, 2019
$171.10M
Oct 30, 2020